Clinical Trial Update: An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism [Phase 3]

View source ↗

Summary

Phase 3 intra-individual titration trial evaluating KRN1493 for treating hypercalcemia in patients with parathyroid carcinoma or intractable primary hyperparath…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercalcemia
• Hyperparathyroidism
• Parathyroid Carcinoma

Drugs mentioned

• KRN1493 (KRN1493)

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Parathyroid Carcinoma, Hypercalcemia | Phase 3 | Status: COMPLETED